Combining recombinant human endostatin with third-generation EGFR-TKIs in advanced EGFR-sensitive mutant non-small cell lung cancer.
Saved in:
| Title: | Combining recombinant human endostatin with third-generation EGFR-TKIs in advanced EGFR-sensitive mutant non-small cell lung cancer. |
|---|---|
| Authors: | Chen J; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China., Huang H; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China., Zhong P; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.; Department of Oncology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China., Lu Z; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China., Ding X; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China., Peng S; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.; Department of Oncology, Huizhou Central People's Hospital, Huizhou, China., Zhu X; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.; Department of Oncology, Heyuan People's Hospital, Heyuan, China., Wang F; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China., Kong P; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China., Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Song T; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China., Xiao F; Department of Pharmacy, The Fourth Affiliated Hospital of Nanchang University, Nanchang, China., Chen L; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. |
| Source: | Journal of thoracic disease [J Thorac Dis] 2025 Jul 31; Vol. 17 (7), pp. 5223-5237. Date of Electronic Publication: 2025 Jul 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AME Publishing Company Country of Publication: China NLM ID: 101533916 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2072-1439 (Print) Linking ISSN: 20721439 NLM ISO Abbreviation: J Thorac Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40809253 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combining recombinant human endostatin with third-generation EGFR-TKIs in advanced EGFR-sensitive mutant non-small cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Huang+H%22">Huang H</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Zhong+P%22">Zhong P</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.; Department of Oncology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Lu+Z%22">Lu Z</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Ding+X%22">Ding X</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Peng+S%22">Peng S</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.; Department of Oncology, Huizhou Central People's Hospital, Huizhou, China.<br /><searchLink fieldCode="AU" term="%22Zhu+X%22">Zhu X</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.; Department of Oncology, Heyuan People's Hospital, Heyuan, China.<br /><searchLink fieldCode="AU" term="%22Wang+F%22">Wang F</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Kong+P%22">Kong P</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Tan+AC%22">Tan AC</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Song+T%22">Song T</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Xiao+F%22">Xiao F</searchLink>; Department of Pharmacy, The Fourth Affiliated Hospital of Nanchang University, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101533916%22">Journal of thoracic disease</searchLink> [J Thorac Dis] 2025 Jul 31; Vol. 17 (7), pp. 5223-5237. <i>Date of Electronic Publication: </i>2025 Jul 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Publishing+Company%22">AME Publishing Company </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101533916 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-1439 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220721439%22">20721439 </searchLink><i>NLM ISO Abbreviation: </i>J Thorac Dis <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40809253 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21037/jtd-2025-1223 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5223 Titles: – TitleFull: Combining recombinant human endostatin with third-generation EGFR-TKIs in advanced EGFR-sensitive mutant non-small cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen J – PersonEntity: Name: NameFull: Huang H – PersonEntity: Name: NameFull: Zhong P – PersonEntity: Name: NameFull: Lu Z – PersonEntity: Name: NameFull: Ding X – PersonEntity: Name: NameFull: Peng S – PersonEntity: Name: NameFull: Zhu X – PersonEntity: Name: NameFull: Wang F – PersonEntity: Name: NameFull: Kong P – PersonEntity: Name: NameFull: Tan AC – PersonEntity: Name: NameFull: Song T – PersonEntity: Name: NameFull: Xiao F – PersonEntity: Name: NameFull: Chen L IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 07 Text: 2025 Jul 31 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2072-1439 Numbering: – Type: volume Value: 17 – Type: issue Value: 7 Titles: – TitleFull: Journal of thoracic disease Type: main |
| ResultId | 1 |